PB3 Real World Adherence, Persistence, Relapse and Multiple Sclerosis Symptoms Among Patients Treated with Oral Disease-Modifying Therapies

2021 ◽  
Vol 24 ◽  
pp. S13
Author(s):  
T. Leist ◽  
H. Le ◽  
S. Verma ◽  
M. Cole ◽  
M. Afolabi ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Real World ◽  
Oral Disease ◽  
Disease Modifying Therapies ◽  
Disease Modifying

Real‐World Effectiveness of Initial Disease‐Modifying Therapies in Pediatric Multiple Sclerosis

2020 ◽  
Vol 88 (1) ◽  
pp. 42-55 ◽  
Author(s):  
Kristen M. Krysko ◽  
Jennifer S. Graves ◽  
Mary Rensel ◽  
Bianca Weinstock‐Guttman ◽  
Alice Rutatangwa ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Real World ◽  
Pediatric Multiple Sclerosis ◽  
Disease Modifying Therapies ◽  
Disease Modifying

scholarly journals Adherence to Glatiramer Acetate 40 Mg Versus Oral Disease-Modifying Therapies for Multiple Sclerosis

2015 ◽  
Vol 18 (7) ◽  
pp. A766 ◽  
Author(s):  
R Halpern ◽  
R Wolbeck ◽  
C Blauer-Peterson ◽  
Y Wu ◽  
SK Gandhi
Keyword(s):  
Multiple Sclerosis ◽  
Glatiramer Acetate ◽  
Oral Disease ◽  
Disease Modifying Therapies ◽  
Disease Modifying

The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis

2016 ◽  
Vol 16 (4) ◽  
Author(s):  
Benedikt Kretzschmar ◽  
Hannah Pellkofer ◽  
Martin S. Weber
Keyword(s):  
Multiple Sclerosis ◽  
Oral Disease ◽  
Disease Modifying Therapies ◽  
Disease Modifying
Sign in / Sign up

Export Citation Format

Share Document